Phase 1 Study of Oral TP-1454

Clinical trial NCT04328740 · COMPLETED

Trial details

NCT number: NCT04328740
Sponsor: Sumitomo Pharma America, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Anal Cancer

Start date: 2020-07-08
Primary completion: 2025-04-25
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.